High or low risk coronary patients - who gets the highest priority?

Area of Science:

• Cardiology
• Health Economics
• Healthcare Policy

Background:

• Coronary revascularisation procedures are frequently performed on patients with low predicted benefit, while high-benefit candidates receive them less often.
• This practice contradicts established clinical guidelines and leads to inefficient allocation of healthcare resources.
• Socioeconomic factors may exacerbate this suboptimal utilization of cardiac interventions.

Discussion:

• The current reimbursement system may inadvertently incentivize the overuse of coronary revascularisation in low-risk populations.
• A shift towards value-based care, rewarding improved patient outcomes, is necessary to align financial incentives with clinical best practices.
• Addressing socioeconomic disparities is crucial for equitable access and appropriate utilization of revascularisation therapies.

Key Insights:

• Suboptimal patient selection for coronary revascularisation represents a significant issue in current cardiovascular care.
• Current healthcare reimbursement structures may not adequately promote the efficient use of revascularisation procedures.
• Evidence-based medicine principles are not consistently applied in the real-world allocation of cardiac interventions.

Outlook:

• Redesigning reimbursement models to incorporate measured improvements in quality of life and survival is proposed.
• Such a system could incentivize clinicians to prioritize revascularisation for patients who stand to gain the most, optimizing resource use.
• Future research should focus on developing and validating robust metrics for quality of life and survival to inform reimbursement policies.